Issued Patents 2023
Showing 1–13 of 13 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11851466 | Targeted IL-12 heterodimeric Fc-fusion proteins | John Desjarlais, Rajat Varma, Ke Liu, Rumana Rashid, Nargess Hassanzadeh-Kiabi +1 more | 2023-12-26 |
| 11840579 | Bispecific antibodies that bind to CD38 and CD3 | Seung Chu, Gregory Moore, John Desjarlais | 2023-12-12 |
| 11814423 | Heterodimeric proteins | Gregory Moore, Rumana Rashid, John Desjarlais | 2023-11-14 |
| 11739145 | Bispecific binding agents binding to CLDN18.2 and CD3 | Alex Nisthal, Gregory Moore | 2023-08-29 |
| 11739144 | Heterodimeric antibodies that bind CD3 and CLDN6 | Matthew S. Faber, Sung-Hyung Lee, Yoon Kyung Kim, Jing Qi, Kendra N. Avery +4 more | 2023-08-29 |
| 11718667 | Optimized antibody variable regions | Gregory Moore, Rumana Rashid, John Desjarlais | 2023-08-08 |
| 11673972 | Heterodimeric antibodies that bind CD3 and tumor antigens | Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid, Umesh Muchhal +1 more | 2023-06-13 |
| 11655277 | IL-12 heterodimeric Fc-fusion proteins | John Desjarlais, Rajat Varma, Ke Liu, Nargess Hassanzadeh-Kiabi, Rumana Rashid | 2023-05-23 |
| 11634506 | Heterodimeric proteins | Gregory Moore, Rumana Rashid, John Desjarlais | 2023-04-25 |
| 11618788 | Optimized antibodies that target CD19 | Seung Chu, John Desjarlais, Sher Bahadur Karki, Gregory Alan Lazar, Erik Weiking Pong +2 more | 2023-04-04 |
| 11618776 | Targeted heterodimeric Fc fusion proteins containing IL-15/IL-15RA and NKG2D antigen binding domains | John Desjarlais, Rajat Varma, Gregory Moore, Juan Diaz, Alex Nisthal +3 more | 2023-04-04 |
| 11584794 | Bispecific heterodimeric fusion proteins containing IL-15-IL-15Ralpha Fc-fusion proteins and immune checkpoint antibody fragments | Rumana Rashid, John Desjarlais, Rajat Varma, Christine Bonzon | 2023-02-21 |
| 11566080 | Compositions and methods for treating IgE-mediated disorders | John Desjarlais, Seung Chu, Holly M. Horton | 2023-01-31 |